Basal serum nitric oxide levels in patients with type 2 diabetes mellitus and different stages of retinopathy

Canadian Journal of Ophthalmology

Volumn 38, Issue 5, 2003, Pages 393-396

  Özden, Serap ^a,c   Tatlipinar, Sinan ^a   Biçer, Nilgün ^b   Yaylali, Volkan ^a   Yildirim, Cem ^a   Özbay, Davut ^a   Güner, Gül ^b  

^a PAMUKKALE UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

^b DOKUZ EYLUL UNIVERSITY   (Turkey)

^c Department of Ophthalmology ^*  (Turkey)

Author keywords

Diabetes mellitus; Diabetic retinopathy; Nitric oxide

Indexed keywords

NITRIC OXIDE;

ARTICLE; BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DIABETIC RETINOPATHY; DISEASE ACTIVITY; DISEASE SEVERITY; HUMAN; NON INSULIN DEPENDENT DIABETES MELLITUS; PATHOGENESIS; SPECTROPHOTOMETRY;

EID: 0142058890     PISSN: 00084182     EISSN: 17153360     Source Type: Journal    
DOI: 10.1016/S0008-4182(03)80051-0     Document Type: Article

References (16)

1. Goldstein IM, Ostwald P, Roth S. Nitric oxide: a review of its role in retinal function and disease. Vision Res 1996;36:2979-94.
2. Jacquemin E, Kozak Y, Thillaye B, Courtois B, Goureau O. Expression of inducible nitric oxide synthase in the eye from endotoxin-induced uveitic rats. Invest Ophthalmol Vis Sci 1996;37:1187-96.
3. Niwa K, Takizawa S, Kawaguchi C, Kamiya U, Kuwahiar I, Shinohara Y. Expression of inducible nitric oxide synthase immunoreactivity in rat brain following chronic hypoxia: effect of aminoguanidine. Neurosci Lett 1999;271:109-12.
4. Merimee TJ. Diabetic retinopathy. A synthesis of perspectives. N Engl J Med 1990;322:978-83.
5. Papapetropoulos A, Garcia-Cardena G, Madri JA, Sessa WC. Nitric oxide production contributes to the angiogenic properties of vascular endothelial growth factor in human endothelial cells. J Clin Invest 1997;100:3131-9.
6. Dawson VL, Brahmbhatt HP, Mong JA, Dawson TM. Expression of inducible nitric oxide synthase causes delayed neurotoxicity in primary mixed neuronal-glial cortical cultures. Neuropharmacology 1994;33:1425-30.
7. Tilton RG, Chang K, Hasan KS, Smith SR, Petrash JM, Misko TP, et al. Prevention of diabetic vascular dysfunction by guanidines: inhibition of nitric oxide synthase versus advanced glycation end-product formation. Diabetes 1993;42:221-32.
8. Navarro-Gonzalvez JA, Garcia-Benayas C, Arenas J. Semiautomated measurement of nitrate in biological fluids. Clin Chem 1998:44:679-81.
9. Maejima K, Nakano S, Himeno M, Tsuda S, Makiishi H, Ito T, et al. Increased basal levels of plasma nitric oxide in type 2 diabetic subjects: relationship to microvascular complications. J Diabetes Complications 2001;15:135-43.
10. Kurenny DE, Moroz LL, Turner RW, Sharkey KA, Barnes S. Modulation of ion channels in photoreceptors by nitric oxide. Neuron 1994;13:315-24.
11. Deussen A, Sonntag M, Vogel R. L-arginine-derived nitric oxide: a major determinant of uveal blood flow. Exp Eye Res 1993;57:129-34.
12. Abu el Asrar AM, Desmet S, Meersschaert A, Dralands L, Missotten L, Geboes K. Expression of inducible isoform of nitric oxide synthase in the retinas of human subjects with diabetes mellitus. Am J Ophthalmol 2001;132:551-6.
13. Hattenbach LO, Allers A, Klais C, Koch F, Hecker M. L-arginine-nitric oxide pathway-related metabolites in the aqueous humor of diabetic patients. Invest Ophthalmol Vis Sci 2000;41:213-17.
14. Yilmaz G, Esser P, Kociek N, Aydin P, Heimann K. Elevated vitreous nitric oxide levels in patients with proliferative diabetic retinopathy. Am J Ophthalmol 200;130:87-90.
15. Abu el Asrar AM, Maimone D, Morse PH, Gregory S, Reder AT. Cytokines in the vitreous of patients with proliferative diabetic retinopathy. Am J Ophthalmol 1992;114:731-6.
16. Chiou SH, Chang CJ, Chou CK, Hsu WM, Liu JH, Chiang CH. Increased nitric oxide levels in aqueous humor of diabetic patients with neovascular glaucoma. Diabetes Care 1999;22:861-2.